CD133+ cells in colon cancer cell lines have a high degree of tumorigenic ability in vivo, and their levels of proliferation, colony formation, and invasive ability were found to be higher than those of CD133− cells in vitro (Ieta et al, 2007). This evidence concerns the gene PROM1 and malignant colon neoplasm.